Overview

• From September 1, the list price for Mounjaro’s highest-dose pen will rise from about £120 to £330 for private retailers covering roughly 1.5 million users.
• NHS England secured a separate discounted deal so prescriptions through the health service remain at the current cost.
• Reports of bulk buying, stockpiling and credit-card debt underscore the squeeze on privately paying patients.
• Professional bodies caution that strained supply and steep prices could drive some to unregulated black-market or counterfeit injections.
• Clinicians advise against abruptly stopping or switching Mounjaro without medical supervision to avoid metabolic instability and loss of blood-sugar control.